Company news
Immuron Limited news in 2023
Immuron Limited's news releases, calls and decks from 2023, newest first.
First Patients Enrolled in Campylobacter Clinical Study
December 4, 2023
Immuron achieves record quarterly Travelan sales
October 11, 2023
Immuron achieves record monthly Travelan sales
September 13, 2023
Immuron Receives TGA GMP Clearance
August 9, 2023
Immuron enrols patients in Travelan clinical study
July 24, 2023
Immuron FY23 Sales increase 136% on FY22 Sales
July 5, 2023
Immuron Initiates Recruitment of Travelan Clinical Study
May 30, 2023
FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic
May 7, 2023
Q3 FY23 Business Update Presentation
April 18, 2023
Immuron Q3 Sales reach 150% of 1H Sales
April 5, 2023
Business Update Presentation
February 27, 2023
Decks in 2023
- Coffee Microcaps Morning Meeting 2023
Conference · 14 slides · Nov 28, 2023
- Coffee Microcaps (November 2023)
Conference · 12 slides · Nov 28, 2023
- Shareholder Meeting (November 2023)
Shareholder meeting · 10 slides · Nov 21, 2023
- Investor Presentation (November 2023)
Investor deck · 13 slides · Nov 13, 2023
- Investor Presentation (November 2023)
Investor deck · 11 slides · Nov 13, 2023
- AusBioInvest 2023
Conference · 10 slides · Oct 30, 2023
- 16th annual LD Micro Main Event 2023
Conference · 14 slides · Oct 4, 2023
- H.C. Wainwright & Co. Virtual Presentation 2023
Conference · 13 slides · Sep 11, 2023
- BioShares Presentation 2023
Conference · 15 slides · Jul 24, 2023
- LD Micro 2023
Conference · 14 slides · Jun 7, 2023
- Coffee Microcaps 2023
Conference · 17 slides · May 2, 2023
- Corporate Update (April 2023)
Corporate update · 11 slides · Apr 19, 2023
- Corporate Update (April 2023)
Corporate update · 13 slides · Apr 19, 2023
- Corporate Update (February 2023)
Corporate update · 14 slides · Feb 28, 2023